JP2010526884A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526884A5 JP2010526884A5 JP2010517230A JP2010517230A JP2010526884A5 JP 2010526884 A5 JP2010526884 A5 JP 2010526884A5 JP 2010517230 A JP2010517230 A JP 2010517230A JP 2010517230 A JP2010517230 A JP 2010517230A JP 2010526884 A5 JP2010526884 A5 JP 2010526884A5
- Authority
- JP
- Japan
- Prior art keywords
- administered
- ribose
- medicament
- dose
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 10
- 206010003658 Atrial fibrillation Diseases 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims 5
- 229940079593 drugs Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
Description
Claims (5)
- 心房細動を経験した人の心房細動を治療するためのD-リボースを含む薬剤。
- 前記D-リボースが1日あたり5から30グラムの服用量で投与されるように投与される請求項1の薬剤。
- 前記D-リボースが1日あたり10から15グラムの服用量で投与されるように投与される請求項1の薬剤。
- 前記D-リボースが、1回の服用量が8グラム以下で投与されるように投与される請求項1の薬剤。
- 前記薬剤が長期間にわたりもしくは恒常的に投与される請求項1の薬剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88194007P | 2007-01-23 | 2007-01-23 | |
US60/881,940 | 2007-01-23 | ||
PCT/US2008/000845 WO2008091618A1 (en) | 2007-01-23 | 2008-01-23 | Use of d-ribose to treat cardiac arrhythmias |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2010526884A JP2010526884A (ja) | 2010-08-05 |
JP2010526884A5 true JP2010526884A5 (ja) | 2011-03-17 |
JP5396387B2 JP5396387B2 (ja) | 2014-01-22 |
Family
ID=39264528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010517230A Active JP5396387B2 (ja) | 2007-01-23 | 2008-01-23 | 心臓不整脈を治療するためのd−リボースの用途 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8101581B2 (ja) |
EP (1) | EP2120968B1 (ja) |
JP (1) | JP5396387B2 (ja) |
CN (1) | CN101588807B (ja) |
AT (1) | ATE487485T1 (ja) |
BR (1) | BRPI0806231A2 (ja) |
CA (1) | CA2674717C (ja) |
DE (1) | DE602008003411D1 (ja) |
ES (1) | ES2352154T3 (ja) |
WO (1) | WO2008091618A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020119933A1 (en) * | 2000-07-28 | 2002-08-29 | Butler Terri L. | Compositions and methods for improving cardiovascular function |
EP2120968B1 (en) | 2007-01-23 | 2010-11-10 | Bioenergy Inc. | Use of d-ribose to treat atrial fibrillations |
CN102387805A (zh) * | 2008-04-02 | 2012-03-21 | 生物能公司 | 核糖在对于急性心肌梗塞的第一反应中的用途 |
JP7082258B2 (ja) | 2016-02-01 | 2022-06-08 | バイオエナジー ライフ サイエンス,インコーポレイティド | うっ血性心不全に罹っている対象を治療するためのリボースの使用 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4719201A (en) | 1985-02-07 | 1988-01-12 | Regents Of The University Of Minnesota | Method for stimulating recovery from ischemia |
US4605644A (en) | 1985-02-07 | 1986-08-12 | Regents Of The University Of Minnesota | Method for stimulating recovery from ischemia employing ribose and adenine |
US4824660A (en) | 1985-06-06 | 1989-04-25 | Paul S. Angello | Method of determining the viability of tissue in an organism |
DE4228215A1 (de) | 1992-08-25 | 1994-03-03 | Pliml Wolfgang | Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen |
RU2127548C1 (ru) | 1996-06-26 | 1999-03-20 | Алабовский Владимир Владимирович | Способ коронарографии в эксперименте |
DE19650754A1 (de) * | 1996-12-06 | 1998-06-10 | Wolfgang Dr Pliml | Ribose und Schlaganfall |
US6218366B1 (en) | 1998-06-19 | 2001-04-17 | Bioenergy, Inc. | Method for raising the hypoxic threshold |
US6159942A (en) | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
US20020119933A1 (en) | 2000-07-28 | 2002-08-29 | Butler Terri L. | Compositions and methods for improving cardiovascular function |
US6429198B1 (en) | 1999-04-12 | 2002-08-06 | Bioenergy Inc. | Compositions for increasing athletic performance in mammals |
US6534480B2 (en) | 1999-06-17 | 2003-03-18 | Bioenergy Inc. | Compositions for increasing energy in vivo |
US6339716B1 (en) | 1999-09-24 | 2002-01-15 | Bioenergy Inc. | Method for determining viability of a myocardial segment |
US6511964B2 (en) | 1999-09-24 | 2003-01-28 | Bioenergy, Inc. | Method for treating acute mountain sickness |
US6159943A (en) | 1999-09-24 | 2000-12-12 | Bioenergy, Inc. | Use of ribose to prevent cramping and soreness in muscles |
US6703370B1 (en) | 1999-10-27 | 2004-03-09 | Bioenergy, Inc. | Use of ribose to treat fibromyalgia |
CA2397344C (en) | 1999-12-21 | 2011-03-15 | Bioenergy Inc. | Compositions for the storage of platelets |
AU2770601A (en) | 2000-01-07 | 2001-07-24 | Bioenergy Inc. | Compositions for enhancing the immune response |
AU2001229672A1 (en) | 2000-01-20 | 2001-07-31 | Bioenergy Inc. | Use of ribose supplementation for increasing muscle mass and decreasing body fatin humans |
US6420342B1 (en) | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
IT1317043B1 (it) * | 2000-06-14 | 2003-05-26 | Sigma Tau Healthscience Spa | Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio. |
US20030212006A1 (en) | 2002-05-13 | 2003-11-13 | Seifert John G. | Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals |
US8486859B2 (en) | 2002-05-15 | 2013-07-16 | Bioenergy, Inc. | Use of ribose to enhance plant growth |
US7687468B2 (en) | 2003-05-14 | 2010-03-30 | Viacell, LLC. | Rejuvenation of stored blood |
US8759315B2 (en) | 2003-05-14 | 2014-06-24 | Viacell, Llc | Methods for rejuvenating |
US20040229205A1 (en) | 2003-05-16 | 2004-11-18 | Ericson Daniel G. | Compositions for the storage of platelets |
WO2005067548A2 (en) | 2004-01-14 | 2005-07-28 | Bioenergy, Inc. | Use of ribose in recovery from anaesthesia |
US20100099630A1 (en) | 2004-04-29 | 2010-04-22 | Maccarter Dean J | Method for improving ventilatory efficiency |
EP1786436B1 (en) | 2004-04-29 | 2012-11-14 | RiboCor, Inc. | Method for improving ventilatory efficiency |
ATE509624T1 (de) * | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
US8835396B2 (en) | 2006-12-15 | 2014-09-16 | Bioenergy, Inc. | Method and compositions for improving pulmonary hypertension |
EP2120968B1 (en) | 2007-01-23 | 2010-11-10 | Bioenergy Inc. | Use of d-ribose to treat atrial fibrillations |
US20080312169A1 (en) | 2007-03-20 | 2008-12-18 | Clarence Albert Johnson | Cosmetic use of D-ribose |
US20090197819A1 (en) | 2007-03-20 | 2009-08-06 | Clarence Albert Johnson | Compositions for improving and repairing skin |
US20090232750A1 (en) | 2008-03-13 | 2009-09-17 | St Cyr John A | Compositions for indoor tanning |
CN102387805A (zh) | 2008-04-02 | 2012-03-21 | 生物能公司 | 核糖在对于急性心肌梗塞的第一反应中的用途 |
US20090286750A1 (en) | 2008-05-16 | 2009-11-19 | Kasubick Robert V | Use of ribose in lessening the clinical symptoms of aberrant firing of neurons |
-
2008
- 2008-01-23 EP EP08713225A patent/EP2120968B1/en active Active
- 2008-01-23 JP JP2010517230A patent/JP5396387B2/ja active Active
- 2008-01-23 US US12/009,933 patent/US8101581B2/en active Active
- 2008-01-23 ES ES08713225T patent/ES2352154T3/es active Active
- 2008-01-23 CN CN2008800029553A patent/CN101588807B/zh active Active
- 2008-01-23 WO PCT/US2008/000845 patent/WO2008091618A1/en active Search and Examination
- 2008-01-23 BR BRPI0806231-5A patent/BRPI0806231A2/pt not_active IP Right Cessation
- 2008-01-23 AT AT08713225T patent/ATE487485T1/de active
- 2008-01-23 DE DE602008003411T patent/DE602008003411D1/de active Active
- 2008-01-23 CA CA2674717A patent/CA2674717C/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016034978A5 (ja) | ||
JP2010522242A5 (ja) | ||
JP2013525444A5 (ja) | ||
JP2012255026A5 (ja) | ||
JP2016508134A5 (ja) | ||
JP2014530874A5 (ja) | ||
JP2009500045A5 (ja) | ||
JP2009513660A5 (ja) | ||
JP2009535352A5 (ja) | ||
JP2019517542A5 (ja) | ||
JP2010529118A5 (ja) | ||
JP2007523135A5 (ja) | ||
JP2014530220A5 (ja) | ||
JP2012501986A5 (ja) | ||
JP2010525055A5 (ja) | ||
JP2017506624A5 (ja) | ||
JP2011225596A5 (ja) | ||
JP2011528333A5 (ja) | ||
CL2008000461A1 (es) | Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos. | |
JP2010536849A5 (ja) | ||
JP2014518860A5 (ja) | ||
JP2016510326A5 (ja) | ||
JP2013541583A5 (ja) | ||
JP2013518124A5 (ja) | ||
JP2015516419A5 (ja) |